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ABSTRACT The intracellular parasite Toxoplasma gondii promotes infection by tar-
geting multiple host cell processes; however, whether it modulates mRNA transla-
tion is currently unknown. Here, we show that infection of primary murine macro-
phages with type I or II T. gondii strains causes a profound perturbation of the host
cell translatome. Notably, translation of transcripts encoding proteins involved in
metabolic activity and components of the translation machinery was activated upon
infection. In contrast, the translational efﬁciency of mRNAs related to immune cell
activation and cytoskeleton/cytoplasm organization was largely suppressed. Mecha-
nistically, T. gondii bolstered mechanistic target of rapamycin (mTOR) signaling to selec-
tively activate the translation of mTOR-sensitive mRNAs, including those with a 5=-
terminal oligopyrimidine (5= TOP) motif and those encoding mitochondrion-related
proteins. Consistent with parasite modulation of host mTOR-sensitive translation to pro-
mote infection, inhibition of mTOR activity suppressed T. gondii replication. Thus, selec-
tive reprogramming of host mRNA translation represents an important subversion strat-
egy during T. gondii infection.
KEYWORDS Toxoplasma gondii, host-pathogen interactions, mTOR, macrophages,
translational control
Toxoplasma gondii, the causative agent of toxoplasmosis, is an obligate intracellularprotozoan parasite that invades virtually all nucleated cells (1) and infects a remark-
ably diverse range of vertebrate hosts, including humans and mice (2, 3). Although
toxoplasmosis is generally asymptomatic, reactivation of encysted parasites can lead to
deleterious consequences for immunosuppressed individuals (1, 4). Furthermore, con-
genital toxoplasmosis can cause spontaneous abortion or severe birth defects (5). To
replicate, T. gondii hijacks host cell organelles and scavenges nutrients (6, 7). In
addition, the parasite targets signaling pathways and affects host cell transcription to
subvert immune functions, promote host cell survival, and modulate host cell processes
to favor its own replication (7–9). Despite this body of evidence, how T. gondii
modulates host cell protein synthesis remains unknown.
Translational control allows cells to rapidly change their proteome to respond to
external triggers or other cues without de novo mRNA synthesis (10, 11). In fact,
modulation of translational efﬁciency represents a critical mechanism in a plethora of
biological processes, such as cell differentiation, metabolism, growth, and proliferation
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(10, 12–14). Accordingly, dysregulation of mRNA translation is a hallmark of various
types of cancer (15, 16) and other clinical disorders, such as inﬂammatory airway
pathologies (17), ﬁbrosis (18), and neurodegenerative diseases (19–22). In eukaryotes,
translation is mainly regulated at the initiation step, during which ribosomes are
recruited to the mRNA, a process which can be modulated via multiple mechanisms.
For instance, the association of mRNAs with RNA-binding proteins (23) and the pres-
ence of features including the 5=-terminal oligopyrimidine (5= TOP) motif (24) or
structured sequence motifs within the 5= untranslated region (UTR) of mRNA (25)
represent regulatory mechanisms selectively inﬂuencing translational efﬁciency. Nota-
bly, ribosome recruitment is facilitated by the recognition of the mRNA 5=-m7G cap
structure by eukaryotic initiation factor 4E (eIF4E), which, together with the scaffold
protein eIF4G and the RNA helicase eIF4A, forms the eIF4F complex (26). Assembly of
the eIF4F complex is prevented by eIF4E-binding proteins (4E-BPs), which block the
eIF4E-eIF4G interaction and eIF4F formation (27, 28). Hyperphosphorylation of 4E-BPs
by the serine/threonine kinase mechanistic target of rapamycin (mTOR) complex 1
(mTORC1) leads to a reduction of the 4E-BPs’ afﬁnity for eIF4E, which favors the
eIF4E-eIF4G interaction and the initiation of translation (29). Thus, signaling through the
mTORC1 axis is pivotal for translational control.
Regulation of mRNA translation efﬁciency is required for normal immune functions
(30) and is altered during infection (31, 32). mTORC1 and its downstream targets
4E-BP1/4E-BP2 and S6K1/S6K2 are key components of the innate immune response
(33–37). Accordingly, changes in mTORC1 signaling are linked to subversion of host
mRNA translation by viruses (38, 39), bacteria (40, 41), and the protozoan parasite
Leishmania major (42).
With regard to toxoplasmosis, translational control has been assessed only in the
parasite (43, 44); however, how the parasite modulates host cell translation is unknown.
Here, we report that T. gondii selectively reprograms the translational landscape of the
host cell to promote its replication. Through a nonbiased approach (i.e., transcriptome-
wide polysome proﬁling), we identiﬁed a large number of transcripts whose translation
efﬁciency is modulated upon infection (i.e., activated or repressed). In addition, we
show that selective activation of host mRNA translation by T. gondii is mTOR sensitive
and is associated with the presence of distinct motifs in the 5= UTRs of identiﬁed
transcripts. Accordingly, inhibition of mTOR activity dampens parasite replication.
Overall, this study provides evidence that selective regulation of host mRNA translation
contributes to T. gondii survival.
RESULTS
Toxoplasma gondii increases protein synthesis in infected macrophages. During
infectious diseases, translational control can act as a host defense mechanism but also
can be exploited by the invading pathogen as a survival strategy (30–32). To explore
these possibilities during T. gondii infection, we inoculated bone marrow-derived
murine macrophages (BMDM) with the RH (type I) and ME49 (type II) strains and
assessed their effects on global protein synthesis by comparing the amounts of
monosomes (inefﬁcient translation) and heavy polysomes (efﬁcient translation), as
observed from polysome tracings. This approach revealed an increase in the amount of
heavy polysomes with a concomitant decrease in the amount of monosomes in T.
gondii-infected cells (Fig. 1A, left). The ratio of the normalized absorbance (254 nm) of
heavy polysomes to monosomes indicated that type I and II strains enhance host cell
protein synthesis to similar extents (mean fold changes over the value for the unin-
fected control [standard deviations {SD}] of 1.59 [0.19] for RH and 1.60 [0.11] for ME49)
(Fig. 1A, right). These observed differences did not result from a contaminating signal
originating from the parasite, as polysome tracings from T. gondii tachyzoites alone
were barely detected (see Fig. S1A in the supplemental material). Thus, T. gondii
infection leads to increased macrophage protein synthesis.
T. gondii infection causes selective modulation of host cell translation. The
increased amount of mRNA associated with heavy polysomes following parasite infec-
Leroux et al. Infection and Immunity











tion is consistent with parasite-induced mRNA-selective and/or global changes in host
cell translational efﬁciency. To resolve the selective regulation of translational efﬁ-
ciency, we used polysome proﬁling, quantiﬁed by transcriptome sequencing (RNA-Seq)
(Fig. 1B). During polysome proﬁling, both efﬁciently translated mRNA (deﬁned here as
mRNA associated with 3 ribosomes) and cytosolic mRNA (input) are isolated and
quantiﬁed. As altered cytosolic mRNA levels will lead to corresponding changes in
polysome-associated mRNA even without a modulation of translational efﬁciency,
differences in polysome-associated mRNA levels require adjustment for changes in
cytosolic mRNA levels to identify bona ﬁde changes in translational efﬁciency. Here, we
used the ANOTA (analysis of translational activity) algorithm for this purpose (45).
Polysome proﬁling coupled with ANOTA of uninfected and RH- or ME49-infected
BMDM revealed widespread selective alterations in translational efﬁciency upon infec-
tion with either strain (Fig. 1C). In total, 322 and 625 mRNAs showed activated and
repressed translational efﬁciencies, respectively, in response to either strain (false
FIG 1 T. gondii infection stimulates protein synthesis and selectively modulates translational efﬁciencies in BMDM. (A) BMDM cultures were inoculated with
either RH or ME49 T. gondii tachyzoites (MOI of 3:1) or left uninfected (control) for 8 h. Cell lysates were sedimented on 5 to 50% sucrose gradients. (Left)
Gradients were fractionated, and the absorbance at 254 nm was recorded continuously. Absorbance values were normalized. Arrows indicate the 40S and 60S
ribosomal subunits and 80S (monosomes). The light and heavy polysome regions were identiﬁed as fractions containing mRNA associated with 2 to 3 and 3
ribosomes, respectively. Polysome tracings are representative of data from at least four independent experiments. (Right) The area under the curve of the
monosome and heavy polysome regions was calculated, and the heavy polysome-to-monosome ratios were then normalized to values for uninfected BMDM
cultures (control) (means [SD]; n  4 biological replicates). (B) Workﬂow strategy to characterize the translatome of T. gondii-infected BMDM. Cytosolic extracts
from control (uninfected) and T. gondii-infected (RH or ME49) BMDM cultures were sedimented on a sucrose gradient. Heavy polysome fractions were pooled
(referred to as heavy polysome-associated mRNA). Total and heavy polysome-associated mRNAs were sequenced by RNA-Seq and analyzed by ANOTA, an R
package (n  3 biological replicates). Validation of genes identiﬁed by RNA-Seq was accomplished with targeted nCounter assays (custom panel; n  3
biological replicates). (C) Densities of FDRs for changes in polysome-associated mRNA, cytosolic mRNA, or translational efﬁciency (i.e., following ANOTA) for each
strain compared to the uninfected control. (D) Scatter plots of log2 fold changes (for the same comparisons as in panel B) for polysome-associated and cytosolic
mRNAs. Transcripts showing altered translational efﬁciencies and mRNAs showing a changed polysome association (which can be explained by altered cytosolic
mRNA levels following, e.g., modulated transcription) are indicated. (C and D) Data analyses were performed on samples generated from three independent
biological replicates.
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discovery rate [FDR] of 0.25) (Fig. 1D; see also Table S1 in the supplemental material).
In contrast, only 51 targets showed translational efﬁciencies modulated differently
between strains RH and ME49 (Fig. S1B and Table S1). We selected 220 targets
regulated via translation and 30 nonregulated genes for validation using a custom-
designed nCounter code set from NanoString Technologies (Table S2). Targets were
selected based on biological functions of the encoded proteins that were of particular
interest (e.g., cell death, metabolism, the immune response, and translation). In addi-
tion, expression levels (similar numbers of low, intermediate, and high levels of
polysome-associated mRNAs) and proportions of the directionality of translational
regulation (1/3 up- and 2/3 downregulated) were also considered selection criteria.
Changes in translational efﬁciency as estimated by RNA-Seq and nCounter assays were
highly correlated (Spearman rank correlation, , values of 0.76 for RH versus the control,
0.76 for ME49 versus the control, and 0.56 for RH versus ME49) (Fig. S1C). Accordingly,
mRNAs identiﬁed as translationally activated or repressed using RNA-Seq largely
showed a consistent directionality of regulation. Thus, both T. gondii strains induce
abundant and similar selective changes in the host cell translational efﬁciency.
T. gondii selectively reprograms translation of mRNAs encoding proteins in-
volved in protein synthesis, cell activation, and cytoskeleton/cytoplasm organi-
zation. To identify functional classes enriched for translationally regulated host mRNAs
and to predict biological processes consequently affected during T. gondii infection, we
used Ingenuity Pathway Analysis (IPA) (46). Within the molecular and cellular functions
IPA classiﬁcation, several functional networks were signiﬁcantly enriched (FDR of
0.05) among proteins encoded by mRNAs whose translation was altered during T.
gondii infection relative to the background (all mRNAs detected by RNA-Seq described
above) (Fig. 2A; see also Table S3 in the supplemental material). The enriched catego-
ries include mRNAs involved in translation, the organization of the cytoskeleton and
cytoplasm, cell activation, and cell movement. Globally, translational efﬁciencies of
targets that belong to these categories displayed similar directionalities of regulation
by RH and ME49 (Fig. 2B). Within the “translation” category, all mRNAs encoding
ribosomal proteins were translationally activated. Conversely, targets grouped in the
category “organization of the cytoplasm and cytoskeleton” were generally repressed.
These transcripts encode proteins involved in membrane dynamics, microtubule-based
movement, organelle formation and organization, and vesicular trafﬁcking (e.g., dy-
neins Dync1H1 and Dync2H1; kinesins Kif11 and Kif3A; and myosins Myh10, Myo6,
Myo7A, Myo10, and Myo18A). Within the category “activation of cells,” translational
efﬁciencies of some mRNAs related to cell movement and chemotaxis were activated
(chemokines Ccl5 and Ccl9), while others were repressed (chemokine receptors Ccr2,
Ccr5, and CxcCr1 and matrix metalloproteases Mmp9 and Mmp13). Although not
classiﬁed in this category by IPA, Mmp8, Mmp11, and Mmp12 were also identiﬁed as
translationally downregulated upon infection (Table S1). Notably, mRNAs encoding
immune cell activators were largely repressed (CD molecules Cd2, Cd93, and Cd180;
interleukin receptors Il2Rb1, Il18Rap, and Il6Ra; and integrins Itgam and Itgav). In stark
contrast, transcripts involved in immune suppression and negative regulation of in-
ﬂammation (e.g., Cd200 and Il1Ra) were more efﬁciently translated in infected cells (Fig.
2B). Interestingly, the translational repression of transcripts promoting cell death was
concomitant with the translational activation of antiapoptotic and cell cycle progres-
sion regulators. For instance, the levels of the negative regulator of cell differentiation
Notch2 and the proapoptotic transcription factor Foxo3a were decreased, whereas the
levels of antiapoptotic and positive regulators of cell cycle progression and macro-
phage differentiation were enhanced (e.g., Bcl2A1D and Hbegf) (Fig. 2B). Consistent with
this, other negative regulators of cell proliferation and differentiation (Bcl6 and Notch4)
were also translationally repressed (Table S1). Thus, T. gondii appears to selectively
modulate the translational efﬁciencies of host mRNAs favoring the survival of infected
cells while reorganizing the host cell architecture and preventing deleterious immune
responses.
Leroux et al. Infection and Immunity











FIG 2 Enriched cell processes for translationally regulated host mRNAs upon T. gondii infection. IPA was
performed on mRNAs translationally regulated by T. gondii infection. (A) FDR values (log10) for select
(Continued on next page)
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T. gondii infection selectively activates mTOR-sensitive translation. We next
assessed whether altered selective translation following parasite infection could be
linked to distinct 5= UTR features. To this end, we ﬁrst calculated the 5= UTR GC content
and length of nonredundant mouse 5= UTRs collected in the RefSeq database (47).
While no signiﬁcant differences in GC content were observed (see Fig. S2A in the
supplemental material), mRNAs translationally activated upon parasite infection had
signiﬁcantly shorter 5= UTRs than the background (all RefSeq mouse 5= UTRs) (Fig. 3A).
Second, we searched for sequence motifs using MEME (Multiple Em for Motif Elicitation)
(48). This analysis identiﬁed a contiguous pyrimidine-rich (CU) motif (E  2.6  1018)
within 223 out of the 322 mRNAs showing activated translation (Fig. 3B and Table S4)
and a GC-rich stretch (E  2.1  10215) in 314 out of the 625 translationally
suppressed transcripts (Fig. S2B and Table S4). Interestingly, the CU motif has some
resemblance to the 5= TOP motif CYn (n  4), where Y represents a pyrimidine
nucleoside (49). TOP-containing mRNAs encode ribosomal proteins and factors for
translation initiation and elongation (eIFs and eukaryotic elongation factors [eEFs])
whose translational efﬁciency is sensitive to mTOR activity (50–52). Indeed, translation
of TOP mRNAs was selectively activated following infection with both parasite strains
(P 0.001 for RH and ME49 versus the control) (Fig. 3C and D and Table S5). In contrast,
the translational efﬁciencies of internal ribosome entry site (IRES)-containing mRNAs were
largely unaffected upon infection (Fig. 3D and Table S5). In addition to TOP mRNAs,
transcripts with short 5= UTRs whose translation is also mTOR-dependent but does not
require a 5= TOP motif, such as those encoding mitochondrion-related proteins (51), were
translationally activated in infected cells (i.e., mRNAs related to mitochondrial translation,
the electron transport chain, the mitochondrial respiratory chain, and the mitochondrial
proton-transporting ATP synthase complex) (Fig. 3E and Table S5).
The data described above indicate that increased mTOR activity underlies a sub-
stantial proportion of parasite-induced changes in the translatome. To directly assess
this, we used a previously reported translation signature (53), consisting of mRNAs
whose translation efﬁciency is suppressed following mTOR inhibition (using PP242 in
the breast carcinoma cell line MCF-7). Indeed, infection with either strain was associ-
ated with selectively activated translation of such mTOR-sensitive mRNAs (P 0.001 for
RH and ME49 versus the control) (Fig. 3F and Table S5). Altogether, these data suggest
that T. gondii selectively augments mTOR-sensitive translation in BMDM.
T. gondii infection increases host mTORC1 activity in BMDM. The translation of
mRNAs whose translational efﬁciency parallels mTOR activity was enhanced in T.
gondii-infected macrophages. Therefore, we next determined mTORC1 kinase activity
by assessing the phosphorylation of its downstream targets, S6K1/S6K2 and 4E-BP1/
4E-BP2. Of note, parasite extracts (i.e., devoid of any host cell [“Tg only”]) were probed
in parallel to rule out the possibility that the observed changes in mTORC1 signaling
were due to cross-reactivity of the antibodies against parasite proteins (Fig. 4A).
Phosphorylation of S6K1 (T389) and levels of S6K2 were increased in BMDM infected
with either the RH or ME49 strain (Fig. 4A). Accordingly, the phosphorylation of the
downstream target of S6K1/S6K2, ribosomal protein S6 (RPS6) (S235, S236, S240, and
S244), was augmented and required active invasion without noticeable bystander
effects (see Fig. S3A in the supplemental material). Phosphorylation of RPS6 in infected
cells was completely abrogated in S6K1//S6K2/ BMDM, conﬁrming that this
cellular response is S6K1/S6K2 dependent (Fig. S3B). In addition, the hierarchical
phosphorylation of 4E-BP1/4E-BP2 (i.e., T37/46, T70, and S65) was induced in T. gondii-
infected BMDM with similar kinetics for the two strains (Fig. 4A). Hyperphosphorylation
FIG 2 Legend (Continued)
biologically relevant IPA categories that were signiﬁcantly enriched in T. gondii-infected cells. (B) Heat
maps showing translational efﬁciency changes for selected genes in enriched categories were generated
by using Morpheus (Broad Institute [see https://software.broadinstitute.org/morpheus/index.html]). For
panels A and B, analyses were carried out on data generated from three independent biological
replicates.
Leroux et al. Infection and Immunity











FIG 3 T. gondii infection selectively activates mTOR-sensitive translation. (A) Cumulative frequency distri
butions of RefSeq 5= UTR lengths across the mm10 genome (black), compared to those of the upregulated
and downregulated sets in RH (top) and ME49 (bottom) infections. (B) Sequence logo of the MEME motif
found in the upregulated 5= UTR set. Nucleotide positions are indicated on the x axis. (C) Venn diagrams
indicating the numbers of genes harboring a TOP motif present in the upregulated versus downregulated
(Continued on next page)
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of 4E-BP1/4E-BP2 was also evident by a mobility shift on SDS-PAGE gels and increased
amounts of the  form compared to the  and  forms. The hyperphosphorylated forms
of 4E-BP1/4E-BP2 have lower afﬁnities for the mRNA 5=-m7G cap-binding protein eIF4E
(29). Consistently, m7GTP pulldown assays revealed a reduced interaction between
4E-BP1/4E-BP2 and m7GTP-bound eIF4E in T. gondii-infected BMDM (Fig. 4B and C).
Treatment with Torin-1, an active-site TOR inhibitor (asTORi) (54), resulted in the
complete dephosphorylation of 4E-BP1/4E-BP2 and strong binding to m7GTP-bound
eIF4E regardless of the infection status of the host cell (Fig. 4B). In summary, T. gondii
activates mTORC1 signaling and promotes the dissociation of 4E-BP1/4E-BP2 from
cap-bound eIF4E in BMDM.
Next, we aimed to elucidate upstream events activating mTORC1 during T. gondii
infection. To this end, we assessed the contribution of AKT, which phosphorylates and
inactivates the mTORC1 repressor TSC2 (55). Pretreatment with a pan-AKT inhibitor,
MK-2206 (56), partially decreased the phosphorylation of RPS6 and 4E-BP1 (Fig. S3C). In
light of these results, we monitored mTORC1 activity in T. gondii-infected BMDM
deprived of L-leucine, an amino acid whose intracellular levels regulate mTORC1 in an
AKT-independent fashion (57). Simultaneous pharmacological inhibition of AKT and
L-leucine starvation abrogated RPS6 and 4E-BP1 phosphorylation in T. gondii-infected
BMDM (Fig. S3C). Altogether, these data suggest that the activation of mTORC1 in T.
gondii-infected BMDM relies on both AKT-dependent and -independent mechanisms.
Inhibition of mTOR reverses T. gondii-induced activation of host mRNA trans-
lation and dampens parasite replication. To further assess whether changes in
translational efﬁciency observed in T. gondii-infected cells depend on mTOR, polysome
tracings were generated from BMDM treated with rapamycin, an allosteric mTORC1
inhibitor, or Torin-1. Rapamycin induced similar shifts from heavy polysomes to mono-
somes in RH- and ME49-infected BMDM (48.3% and 37.2% reductions, respectively) (Fig.
5A and B). As expected, Torin-1 exerted a more dramatic effect than rapamycin (RH,
62.2%; ME49, 62.5%), owing to its greater potency (54). Of note, no differences in
infection rates and no acute toxicity were observed for parasites exposed to the
inhibitors (see Fig. S4 in the supplemental material). While rapamycin and Torin-1
abrogated the phosphorylation of S6K1 (T389) and its downstream target RPS6 (S235,
S236, S240, and S244) in T. gondii-infected BMDM, only Torin-1 completely abolished
4E-BP1/4E-BP2 phosphorylation (as described previously [58]) (Fig. 5C). To evaluate
whether chemical inhibition of mTOR is sufﬁcient to reverse the translation program
induced following parasite infection, we performed polysome proﬁling, quantiﬁed by
nCounter assays (same targets as the ones described above) (Table S2), in T. gondii-
infected and uninfected BMDM treated with rapamycin or Torin-1. We next assessed
how fold changes in polysome-associated and cytosolic mRNA levels (for the subset of
mRNAs translationally activated upon infection by either RH or ME49) were affected in
cells treated with rapamycin or Torin-1. This approach revealed that chemical inhibition
of mTOR is sufﬁcient to largely reverse the effects on selective translation induced
during parasite infection (Fig. 5D and Table S6).
As parasite infection appears to profoundly affect host cell properties essential for
the synthesis of biomolecules and growth by perverting host mTOR-sensitive mRNA
translation, we hypothesized that the upregulation of mTOR activity constitutes a
FIG 3 Legend (Continued)
gene sets. (D) Cumulative distribution of translational efﬁciencies of TOP mRNAs, IRES-containing mRNAs,
and the background (all transcripts). (E) Cumulative distribution of translational efﬁciencies of mRNAs
related to mitochondrial translation, the electron transport chain, mitochondrial respiratory chain complex
I, mitochondrial respiratory chain complex IV, the proton-transporting ATP synthase complex, and the
background (all transcripts). (F) Cumulative distribution of translational efﬁciencies of mRNAs whose
translation was previously deﬁned as depending on mTOR activity and the background (transcripts not
belonging to the gene signature). For panels D to F, changes in translational efﬁciencies between
RH-infected (left) or ME49-infected (right) BMDM and uninfected cells were evaluated. P values determined
by a Wilcoxon test are indicated (tests consider genes belonging versus those not belonging to each
group). ECDF, empirical cumulative distribution function. For panels A to F, data analyses were conducted
on samples obtained from three independent biological replicates.
Leroux et al. Infection and Immunity











FIG 4 T. gondii augments mTORC1 activity and promotes 4E-BP1/4E-BP2 dissociation from cap-bound
eIF4E in BMDM. (A) BMDM cultures were inoculated with either RH or ME49 T. gondii tachyzoites or left
(Continued on next page)
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parasite survival strategy. To test this, BMDM were pretreated with either rapamycin or
Torin-1 and infected with either RH or ME49 T. gondii tachyzoites. Parasites were
allowed to egress and reinfect new host cells for 72 h, after which parasite numbers
were evaluated by quantitative PCR (qPCR). Rapamycin treatment had a modest effect
on parasite proliferation (12.8% and 19.5% reductions for RH and ME49, respectively),
while Torin-1 caused a more pronounced reduction in replication (57.1% and 55.1%,
respectively) than did dimethyl sulfoxide (DMSO) treatment (Fig. 5E). These data
indicate that T. gondii relies on augmenting mTOR activity for unhindered replication.
DISCUSSION
Translational control of gene expression is a central mechanism of host defense (31,
32). As such, pathogens hijack the host translation machinery to survive (31, 32). Using
transcriptome-wide polysome proﬁling, we demonstrate that the protozoan parasite T.
gondii selectively augments mTOR-sensitive translation to favor host cell survival and
parasite replication. Type I and II T. gondii strains regulate mTOR activity and mRNA
translation in similar fashions, suggesting that this is a core process needed for parasite
propagation that does not depend on strain-speciﬁc virulence factors. Further support-
ing the notion that regulation of mTOR-sensitive mRNA translation constitutes a
parasite survival strategy, mTOR inactivation dampened T. gondii replication.
Our data on the activation of mTOR signaling are consistent with those of a recent
analysis of the phosphoproteome of T. gondii-infected human foreskin ﬁbroblasts (HFF)
showing an enrichment of phosphorylated proteins both up- and downstream of
mTOR, including RPS6 and 4E-BP1 (59). Interestingly, Wang and colleagues had previ-
ously reported that the phosphorylation of S6K1 following T. gondii infection was not
consistently observed in different host cell lines (HFF, 3T3, and HeLa) (60–62). In some
cases, no increased or prolonged phosphorylation of S6K1 was observed (60, 61), while
in others, sustained and augmented phosphorylation was detected (62). To resolve the
S6K-dependent phosphorylation of S6 in our experimental setting, we combined a
chemical approach (i.e., mTOR inhibitors) and a genetic approach (i.e., BMDM derived
from s6k1/s6k2 double-knockout [DKO] mice) that conﬁrmed the requirement for S6K1
and S6K2 activity for RPS6 phosphorylation in T. gondii-infected macrophages. Our
results showing inducible and sustained phosphorylation of 4E-BP1 following infection
are also in sharp contrast to those of Wang and colleagues, who reported the absence
of this phenomenon in T. gondii-infected 3T3 and HeLa cells (60, 61). This discrepancy
might be related to distinct signals triggered by T. gondii depending on the species
and/or the type of host cell, which could result in the differential activation of mTOR
effectors. Further characterization of mTOR outputs in immune and nonimmune cell
populations will shed light on this matter. The mechanism by which T. gondii upregu-
lates mTOR activity appears to be multifactorial, as indicated by the requirement for
both AKT-mediated signaling and AKT-independent events, such as L-leucine availabil-
ity. Amino acid abundance promotes Rag-dependent translocation and activation of
mTORC1 at the lysosomal surface (63). Notably, mTOR associates with the parasito-
phorous vacuole (PV) in T. gondii-infected cells (60). Those observations, along with our
FIG 4 Legend (Continued)
uninfected for the indicated times. Phosphorylation and expression levels of indicated proteins were
monitored by Western blotting. Total amounts of -actin were used as a loading control, and an antibody
against T. gondii proﬁlin-like protein was employed to assess infection of BMDM cultures. Total protein
extracts from extracellular tachyzoites (both the RH and ME49 strains) (Tg only) were used to control for
any cross-reactivity of the antibodies against T. gondii proteins. (B) BMDM cultures were pretreated with
200 nM Torin-1 or an equal volume of DMSO (vehicle) for 2 h and then inoculated with either RH or ME49
T. gondii tachyzoites or left uninfected. Total protein extracts were collected at 8 h postinfection and
prepared for m7GTP pulldown assays. Levels of the indicated proteins in the input (15 g), pulled-down
material (20%), and ﬂowthrough (FT) (15 g) were determined by Western blotting. (C) Ratios of
m7GTP-bound 4E-BP/eIF4E were calculated based on densitometric measurements of the band intensi-
ties of 4E-BP1, 4E-BP2, and eIF4E and normalized to values for the uninfected BMDM control (means [SD];
n  3 biological replicates). For panels A and B, data are representative of results from at least three
independent biological replicates. **, P  0.01.
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FIG 5 Inhibition of mTOR reverses T. gondii-induced activation of host mRNA translation and dampens
parasite replication. BMDM cultures were pretreated with 20 nM rapamycin, 200 nM Torin-1, or an equal
volume of DMSO (vehicle) for 2 h and then inoculated with either RH or ME49 T. gondii tachyzoites or left
(Continued on next page)
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data, suggest that the PV surface offers a favorable site for mTORC1 activation during
T. gondii infection.
Chemical inhibition of mTOR allowed us to conﬁrm its requirement for selective
translational activation in T. gondii-infected macrophages. Consistent with this, numer-
ous mRNAs containing a 5= TOP motif were present exclusively among translationally
activated mRNAs, including those encoding ribosomal proteins. Interestingly, several of
them play a role in cell cycle progression (e.g., RPS3, RPS7, RPS15a, RPL15, and RPL36a)
and the regulation of apoptosis (e.g., RPS14, RPS29, and RPL7) (64). Moreover, T. gondii
suppressed the translation of macrophage mRNAs encoding proapoptotic proteins,
such as Foxo3a, while leading to the translational activation of prosurvival factors and
cell cycle regulators (e.g., Bcl2A1D, Cdk2, Hbegf, and Id2). T. gondii has the ability to
inhibit apoptosis and regulate the host cell cycle to promote infection (65–68). More-
over, mTOR activity is required for host cell cycle progression during T. gondii infection
(60). In view of those studies and our present ﬁndings, T. gondii appears to regulate the
translational efﬁciency of select mRNAs that favor the survival of the infected cell and
ultimately enhance parasite replication.
Enrichment for transcripts encoding proteins related to cell activation and move-
ment was mainly associated with translational repression by T. gondii. Strikingly, several
of these factors are critical during toxoplasmosis. For instance, mice deﬁcient in Ccr2
fail to recruit Gr1 inﬂammatory monocytes to the intestine and are susceptible to oral
challenge with T. gondii cysts (69). Similarly, genetic deletion of Ccr5 increases suscep-
tibility to toxoplasmosis, and signaling through this receptor is required for
interleukin-12 (IL-12) production by dendritic cells in response to T. gondii (70). In stark
contrast, Cd200, whose translational efﬁciency was activated in T. gondii-infected
macrophages, has a detrimental effect during chronic toxoplasmosis. Indeed, CD200
expression downregulates microglial activation in the brain of T. gondii-infected mice.
Accordingly, Cd200/ mice display an efﬁcient local antiparasitic response (71). Those
studies, along with our data, indicate that selective translational control of immune-
related genes by T. gondii contributes to its ability to subvert protective immune
responses.
Numerous mRNAs pertaining to mitochondrial functions were translationally acti-
vated upon T. gondii infection, including mitoribosomal proteins, factors implicated in
the electron transport chain, and ATP synthases. These data are consistent with the
mTOR-sensitive translation of mRNAs encoding proteins related to mitochondrial bio-
genesis and functions (72, 73). With regard to T. gondii, it is well documented that the
PV associates with the host mitochondria (74–76). Accumulating evidence indicates
FIG 5 Legend (Continued)
uninfected (control) for 8 h. (A) Polysome tracings representative of data from at least four independent
biological replicates. a.u., arbitrary units. (B) Heavy polysome-to-monosome ratios normalized to values
for DMSO-treated uninfected BMDM cultures (control) (means [SD]; n  4 biological replicates). (C) A
fraction of the cultures utilized for polysome tracings was used to collect total protein extracts. The
phosphorylation status and expression levels of the indicated proteins were monitored by Western
blotting. Data are representative of results from four separate experiments. (D) Transcripts showing
activated translational efﬁciencies following parasite infection were selected, and their mTOR-sensitive
translation was assessed by using polysome proﬁling coupled to nCounter assays (same treatments as for
panel A). The cumulative distributions of log2 fold changes for these targets were compared to the
background (all other nCounter-quantiﬁed mRNAs) in infected cells with or without rapamycin or Torin-1
treatment and compared to values for uninfected DMSO controls. Empirical cumulative distribution
functions (ECDF) are shown for log2 fold changes for cytosolic mRNA and polysome-associated mRNA.
UP, upregulated. P values for comparison of selected targets with their corresponding background,
determined by Wilcoxon tests, are given. Data analyses were conducted on samples obtained from three
independent biological replicates. (E) BMDM were pretreated with 20 nM rapamycin, 200 nM Torin-1, or
an equal volume of DMSO (vehicle) for 2 h and then inoculated with either RH or ME49 T. gondii
tachyzoites at a parasite-to-BMDM ratio of 1:20 for 72 h. Genomic DNA was extracted, and parasite
replication was assessed by qPCR by ampliﬁcation of the T. gondii B1 gene. CT values were normalized
to the value for mouse -actin, and effects of the inhibitors on parasite replication were calculated by
normalization to values obtained from cultures treated with DMSO for each strain. Values from one
representative experiment of two independent trials are presented as means (SD); experiments on all
samples were performed in technical triplicates. *, P  0.05; **, P  0.01; ***, P  0.001.
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that this association not only provides the parasite with nutrients, such as amino acids
and glucose (77), but also leads to altered oxidative phosphorylation (OXPHOS) (78) and
impacts innate immune responses (79). Moreover, the metabolism of intracellular T.
gondii tachyzoites appears to rely on host-derived ATP (80), and parasite egress is
particularly sensitive to host cell ATP levels (81). Therefore, it is plausible that the
translational control of select host mRNAs by T. gondii contributes to the subversion of
host mitochondrial functions, which in turn favors parasite metabolic activity and
replication. Future studies should therefore aim to address these issues.
Several genes related to autophagy were identiﬁed in our study as translationally
repressed in T. gondii-infected cells (e.g., Atp13a2, Htr2b, Iigp1, Kdr, Lrrk2, Nbr1, Tecpr1,
Tpcn1, Trim21, and Wdfy3), while others were activated (e.g., Hspa8 and Mefv). Inter-
estingly, host autophagy appears to have a dual role during T. gondii infection since it
provides macromolecules to replicating parasites (82) but also contributes to parasite
clearance by stripping the PV membrane (83). TRIM20, encoded by the MEFV gene, is
induced by gamma interferon (IFN-) and is involved in “precision autophagy,” by
speciﬁcally targeting the inﬂammasome components NLRP3, procaspase 1, and NLRP1
to limit excessive inﬂammation (84). Therefore, by favoring the translational efﬁciency
of MEFV, it possible that the parasite aims at limiting inﬂammasome activation, a
mechanism required for host resistance against T. gondii (85, 86). Translational repres-
sion of Iigp1 and Trim21 could also favor parasite persistence within the infected cell.
IIGP1 (or Irga6) is targeted and inactivated by the parasite virulence factor kinase
complex ROP5/ROP18/GRA7 (87) to prevent immune-related GTPase (IRG)-mediated
destruction of the parasite (88, 89). Similarly, TRIM21 accumulates at the PV membrane
following IFN- stimulation to restrict parasite replication and modulate inﬂammatory
cytokine production in T. gondii-infected cells (90). Moreover, Trim21-deﬁcient mice are
more susceptible to toxoplasmosis and display higher parasite burdens and lower
proinﬂammatory cytokine levels. Hence, it is tempting to suggest that modulation of
translational efﬁciency of host mRNAs involved in autophagy constitutes an additional
mechanism employed by T. gondii to promote infection.
In addition to the identiﬁcation of pyrimidine-rich (CU) motifs in the 5= UTR of
mRNAs translationally activated upon T. gondii infection, 5= UTR analysis indicated the
presence of GC-rich stretches in 50% of the mRNAs that are translationally repressed.
Of interest, this feature was absent in the mRNAs whose translation was activated upon
parasite infection. GC-rich motifs in the 5= UTR are associated with the formation of
secondary structures that limit mRNA translation efﬁciency (91, 92). Translational
control is also achieved via trans-regulatory factors, such as RNA-binding proteins,
microRNAs, and “specialized ribosomes” (93–95). A recent study by Fischer and col-
leagues reported that infection by T. gondii causes the formation of stress granules
containing poly(A)-binding proteins (PABPs) in the nucleus of the host cell (96). PABPs
regulate several steps in mRNA processing, such as export, degradation, stability,
polyadenylation, and deadenylation (97, 98). Upon stress (e.g., UV irradiation or viral
infection), mRNA can be stored in nuclear stress granules through interactions with
PABPs leading to translational silencing (99). Further investigation is needed to deﬁne
the role of PABPs in translational control during T. gondii infection. It is conceivable that
numerous mechanisms act in concert during T. gondii infection to ﬁne-tune selective
host mRNA translation.
Collectively, this study deﬁnes the translational signature of macrophages infected
by T. gondii and provides evidence that translational control constitutes a key mech-
anism of host cell subversion by the parasite. Further supporting a central role for
posttranscriptional regulatory mechanisms of gene expression during toxoplasmosis, a
lack of correlation between transcriptomic and proteomic data was reported for human
ﬁbroblasts infected by T. gondii (100). Thus, it is likely that by modulating translation
efﬁciencies in different cell types, T. gondii promotes its survival and dissemination
through the infected host. Future studies using in vitro and in vivo models of T. gondii
infection will contribute to a better understanding of the impact and the mechanisms
underlying the regulation of mRNA translation during toxoplasmosis.
Dysregulation of Host mRNA Translation by T. gondii Infection and Immunity












Reagents. Culture media and supplements were purchased from Wisent and Gibco; cycloheximide
(CHX) was purchased from BioShop; CellTracker green CMFDA (5-chloromethylﬂuorescein diacetate) dye
was purchased from Molecular Probes; RNasin was provided by Promega; rapamycin (sirolimus) was
bought from LC Laboratories; Torin-1 and MK-2206 were purchased from Cayman; pyrimethamine was
obtained from Tocris; XTT [2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide]
was ordered from Biotium; [5,6-3H]uracil was purchased from Perkin-Elmer; cOmplete EDTA-free protease
inhibitor and PhosSTOP phosphatase inhibitor tablets were purchased from Roche; DAPI (4=,6-diamidino-
2-phenylindole dilactate) and CellTracker green (CMFDA) were acquired from Invitrogen; and primary
and secondary antibodies for Western blotting and microscopy were purchased from Cell Signaling
Technologies, Santa Cruz Biotechnology, R&D Systems, Sigma-Aldrich, BioLegend, and Invitrogen.
Parasite maintenance and harvest. Toxoplasma gondii tachyzoite cultures (RH and ME49 strains)
were maintained by serial passages in Vero cells kindly provided by Angela Pearson (INRS-Institut
Armand Frappier, Laval, QC, Canada), and cells were grown in Dulbecco’s modiﬁed Eagle’s medium
(DMEM) supplemented with 5% heat-inactivated fetal bovine serum (FBS), 2 mM L-glutamate, 1 mM
sodium pyruvate, 100 U/ml penicillin, and 100 g/ml streptomycin and incubated at 37°C with 5% CO2.
For experimental infections, freshly egressed tachyzoites (RH and ME49 strains) were harvested from Vero
cultures, pelleted by centrifugation (1,300  g for 7 min at 4°C), resuspended in ice-cold phosphate-
buffered saline (PBS) (pH 7.2 to 7.4), and passed through a syringe ﬁtted with a 27-gauge needle. Large
cellular debris and intact host cells were pelleted by low-speed centrifugation (200  g for 3 min at 4°C),
and the supernatant containing parasites was ﬁltered with a 3-m polycarbonate ﬁlter (Millipore).
Tachyzoites were then washed twice in PBS and ﬁnally resuspended in the appropriate culture medium,
according to the experiment.
Bone marrow-derived macrophage differentiation. Bone marrow-derived macrophages (BMDM)
were obtained by differentiating precursor cells from murine bone marrow (101). Brieﬂy, mice were
euthanized by CO2 asphyxiation, hind legs were collected in Hanks’ balanced salt solution (HBSS) (100
U/ml penicillin, 100 g/ml streptomycin, 4.2 mM sodium bicarbonate), and marrow was ﬂushed out of
bones. Red blood cells were lysed in ACK lysis buffer (150 mM NH4Cl, 10 mM KHCO3, 0.1 mM EDTA) for
7 min at room temperature (RT). Precursor cells were washed in HBSS, resuspended in BMDM culture
medium (DMEM, 10% heat-inactivated FBS, 2 mM L-glutamate, 1 mM sodium pyruvate, 100 U/ml
penicillin, 100 g/ml streptomycin, 20 mM HEPES, 55 M -mercaptoethanol) supplemented with 15%
L929 ﬁbroblast-conditioned culture medium (LCCM), seeded into tissue culture-treated dishes, and
incubated overnight at 37°C with 5% CO2. The following day, cells that had not adhered were collected,
resuspended in BMDM culture medium supplemented with 30% LCCM, and plated in regular petri dishes
(i.e., 3  106 precursor cells per dish). Medium was changed 2 days later, and differentiated BMDM were
collected 7 days after marrow extraction. Differentiation of precursor cells into macrophages was
routinely assessed by monitoring CD11b and F4/80 coexpression by ﬂow cytometry. Hind legs from
s6k1//s6k2/ C57BL/6 mice were kindly provided by Nahum Sonenberg (McGill University).
Ethics statement. Experiments were carried out under a protocol approved by the Comité Institu-
tionnel de Protection des Animaux of the INRS-Institut Armand Frappier (CIPA number 1502-03). This
protocol respects procedures on good animal practice provided by the Canadian Council on Animal Care.
Infection of BMDM.Macrophages were plated 1 day before infection with T. gondii in BMDM culture
medium without LCCM and allowed to adhere overnight at 37°C with 5% CO2. Cultures were serum
starved for 2 h and treated with inhibitors, when applicable. BMDM were then inoculated with parasites
(RH or ME49) or left uninfected in fresh medium with 1% FBS. Any remaining extracellular parasites were
rinsed away with warm PBS (pH 7.2 to 7.4) 1 h following inoculation; fresh medium was added with
inhibitors, when applicable; and cells were incubated until the end of the experiment. Unless speciﬁed
otherwise, this procedure was carried out for all in vitro experiments.
Western blot analysis. Cultures were collected following infection and other treatments and lysed
in ice-cold radioimmunoprecipitation assay (RIPA) lysis buffer (25 mM Tris [pH 7.6], 150 mM NaCl, 1%
Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS) supplemented with phosphatase and EDTA-free
protease inhibitor cocktails (Roche, Basel, Switzerland). Insoluble material was removed by centrifugation
(20,000  g for 15 min at 4°C), and the protein concentration in the supernatant was measured by the
bicinchoninic acid (BCA) assay, according to the manufacturer’s speciﬁcations. About 20 g of the
protein sample was mixed with Laemmli loading buffer and subjected to SDS-PAGE, and the resolved
proteins were transferred onto polyvinylidene diﬂuoride (PVDF) membranes. Membranes were blocked
for 1 h at RT in Tris-buffered saline (TBS)–0.05% Tween 20 plus 5% skim milk and then probed with the
following primary antibodies: anti-4E-BP1, anti-phospho-4E-BP1 (T37/46), anti-phospho-4E-BP1 (T70),
anti-phospho-4E-BP1 (S65), anti-4E-BP2, anti-phospho-RPS6 (S235/236), anti-phospho-RPS6 (S240/244),
anti-phospho-S6K1, anti-S6K2, anti-AKT, anti-phospho-AKT (T308), anti-phospho-AKT (S473), and -actin
were obtained from Cell Signaling Technologies; anti-RPS6 and anti-S6K1 were purchased from Santa
Cruz Biotechnology; anti-eIF4E was purchased from BD Biosciences; and anti-T. gondii proﬁlin-like protein
was purchased from R&D Systems. Membranes were then probed with either goat anti-rabbit, goat
anti-mouse (Sigma-Aldrich), or rabbit anti-goat (R&D Systems) IgG horseradish peroxidase (HRP)-linked
antibodies. Subsequently, proteins were visualized by using the Clarity ECL Western blotting substrate
(Bio-Rad) and exposing the membranes to autoradiography ﬁlm (Denville Scientiﬁc, Holliston, MA) or a
chemiluminescence imager (Bio-Rad).
m7GTP-agarose pulldown assay. BMDM cultures were plated in 10-cm-diameter plates in complete
medium and allowed to adhere overnight at 37°C with 5% CO2. Cultures were serum starved for 2 h in
the presence of DMSO (vehicle), 20 nM rapamycin, or 200 nM Torin-1 and then inoculated with T. gondii
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tachyzoites (RH and ME49 strains) at a multiplicity of infection (MOI) of 6:1 or left uninfected in fresh
medium with 1% heat-inactivated FBS. Any remaining extracellular parasites were rinsed away with
warm PBS (pH 7.2 to 7.4) 1 h following inoculation, fresh medium was added, and cells were incubated
for an additional 7 h. Cultures were washed with ice-cold PBS, gently scraped, and pelleted by
centrifugation (200  g for 10 min at 4°C). Cells were lysed in ice-cold buffer A (lysis buffer) (50 mM
morpholinepropanesulfonic acid [MOPS] [pH 7.4], 100 mM NaCl, 2 mM EDTA, 2 mM EGTA, 1% IGEPAL
CA-630, 1% sodium deoxycholate, 7 mM -mercaptoethanol) supplemented with phosphatase and
EDTA-free protease inhibitor cocktails (Roche). Samples were incubated for 15 min on ice and regularly
mixed gently, and the crude lysates were cleared by centrifugation (16,000  g for 10 min at 4°C). The
supernatant was transferred to new tubes, and the protein concentration was measured by the Bradford
assay (Bio-Rad), according to the manufacturer’s speciﬁcations. About 0.5 to 0.75 mg of proteins of each
sample was mixed with a 50% slurry of 2=/3=-ethylenediamine-m7GTP immobilized on agarose beads
(Jena Bioscience) and diluted up to 1 ml with buffer B (wash buffer) (50 mM MOPS [pH 7.4], 100 mM NaCl,
0.5 mM EDTA, 0.5 mM EGTA, 7 mM -mercaptoethanol, 0.1 mM GTP) supplemented with phosphatase
and EDTA-free protease inhibitor cocktails (Roche). Samples were mixed for 1 h at 4°C with end-over-end
(EOE) rotation. Beads were pelleted by centrifugation (500  g for 1 min at 4°C). The supernatants (i.e.,
ﬂowthrough [FT]) were kept, while the beads were washed twice in buffer B and ﬁnally resuspended in
Laemmli loading buffer for further analysis by Western blotting.
Polysome-tracing analysis. BMDM cultures were plated in 15-cm-diameter plates overnight; serum
starved for 2 h in the presence or absence of the vehicle (DMSO), 20 nM rapamycin, or 200 nM Torin-1; and
then inoculated with T. gondii tachyzoites (RH and ME49 strains) at an MOI of 3:1 or left uninfected in fresh
medium with 1% heat-inactivated FBS. After 8 h of infection, CHX was added to cultures to a ﬁnal
concentration of 100 g/ml, and plates were incubated for 5 min at 37°C with 5% CO2. Cells were then rinsed
with cold PBS containing 100 g/ml CHX, scraped, and pelleted by centrifugation (200 g for 10 min at 4°C).
Pellets were lysed in hypotonic lysis buffer (5 mM Tris [pH 7.5], 2.5 mMMgCl2, 1.5 mM KCl, 2 mM dithiothreitol
[DTT], 0.5% Triton X-100, 0.5% sodium deoxycholate, 100 g/ml CHX, and 200 U RNasin RNase inhibitor
[Promega, Madison, WI]), and lysates were cleared by centrifugation (20,000  g for 2 min at 4°C). Lysates
were loaded onto 5 to 50% sucrose density gradients (20 mM HEPES [pH 7.6], 100 mM KCl, 5 mM MgCl2, 100
g/ml CHX, and 200 U RNasin) and centrifuged in a Beckman SW41 rotor at 36,000 rpm for 2 h at 4°C.
Gradients were fractionated and collected (30 s and 500 l per fraction), and the absorbance at 254 nm was
recorded continuously by using a Brandel BR-188 density gradient fractionation system.
Puriﬁcation of RNA. Efﬁciently translated mRNA (associated with3 ribosomes) and the input material
(total cytoplasmic mRNA) were extracted with TRIzol (Invitrogen) and chloroform, followed by isopropanol
precipitation. In brief, polysome fractions and input material were diluted up to 1ml with RNase-free H2O, and
500 l of TRIzol and 150 l of chloroform were then added. Samples were vortexed vigorously for 5 s,
incubated for 3 min at RT, and centrifuged (18,000 g for 15 min at 4°C). The aqueous phase of each sample
wasmixed with an equal volume (750l) of ice-cold isopropanol and 1l of GlycoBlue (Thermo Fisher), and
the RNA was then precipitated overnight at 20°C and pelleted by centrifugation (18,000  g for 10 min at
4°C). The RNA pellet was washed twice with 500 l of 75% ice-cold ethanol. Samples were air dried and
resuspended in RNase-free H2O, and polysome fractions from the corresponding treatment were pooled. RNA
was further cleaned by using an RNeasy MinElute cleanup kit (Qiagen), according to the manufacturer’s
speciﬁcations. Finally, the approximate concentration, purity, and integrity of the puriﬁed RNA were assessed
spectrophotometrically by using a NanoDrop 1000 instrument (Thermo Fisher) and a Bioanalyzer 2100
instrument with a eukaryote total RNA nanochip (Agilent Technologies). Samples were aliquoted and stored
at 80°C until further analyses.
RNA-Seq data processing. Library preparation and sequencing were carried out at SciLifeLab
(Stockholm, Sweden). RNA-Seq libraries were generated by using the strand-speciﬁc TruSeq protocol and
sequenced by using an Illumina HiSeq2500 instrument with a single-end 51-base sequencing setup for
both total cytosolic and polysome-associated mRNAs (mRNAs associated with 3 ribosomes) from three
independent biological replicates. RNA-Seq reads from infected samples were ﬁrst aligned to T. gondii
reference genomes of GT1 (type I) and ME49 (type II) (the genome of the RH strain is not completely
annotated, but it was estimated that among T. gondii RH gene families, 97.8% have orthologs in the GT1
strain [102]). Reads from infected samples that did not map to the T. gondii genomes as well as all reads
from uninfected samples were aligned to the mouse genome mm10. HISAT2 was used for all alignments,
with default settings (103). Alignments to T. gondii and Mus musculus resulted in 4.4% and 93.7%
mappings on average, respectively. Gene expression was quantiﬁed by using the RPKMforgenes.py script
(http://sandberg.cmb.ki.se/media/data/rnaseq/rpkmforgenes.py) (104) with options -fulltranscript
-readcount -onlycoding, from which raw per-gene RNA-Seq counts were obtained (version last modiﬁed
2 July 2014). Annotation of genes was done by using RefSeq. Genes that had zero counts in all samples
were removed. One replicate from the uninfected control condition was excluded from downstream
analysis based on outlier behavior in principal-component analyses.
RNA-Seq analysis of the empirical data set using ANOTA. The limma::voom R function was used
to compute log2 counts per million (105). To identify changes in translational efﬁciency leading to altered
protein levels, ANOTA (45, 106) was used with the following parameters: minimum slope (minSlope) of
0.5 and maximum slope (maxSlope) of 1.5. Replicate was included as a batch effect in the models. The
following criteria were considered for signiﬁcant changes in translational efﬁciency: a false discovery rate
(FDR) of 0.25, a translational efﬁciency (apvEff) of log2(1.5), a log ratio of polysome-associated mRNA
data to cytosolic mRNA data (deltaPT) of log2(1.25), and a polysome-associated mRNA log fold change
(deltaP) of log2(1.5). Genes that overlap, resulting in RNA sequencing reads that cannot be associated
with only one gene, were excluded from downstream analyses. Similar FDR and fold change thresholds
Dysregulation of Host mRNA Translation by T. gondii Infection and Immunity











were used when selecting differential expression of polysome-associated mRNAs. For further analysis, we
used a previously reported list of TOP- and IRES-containing mRNAs (107), mitochondrion-related function
genes included in the Gene Ontology (GO) (2015) terms indicated in Table S5 in the supplemental
material, and a signature for mTOR-sensitive translation (53); gene symbols were converted from human
to mouse and are listed in Table S5. The difference in log2 fold changes of translational efﬁciencies
between the signatures and the background was assessed by using Wilcoxon-Mann-Whitney tests.
nCounter analysis. For nCounter analysis (NanoString Technologies), a subset of 250 genes was
selected according to RNA-Seq data. Sequences for the probes in the custom-designed nCounter code
set are listed in Table S2 in the supplemental material. Infected and uninfected cells were treated with
rapamycin or Torin-1, followed by the isolation of efﬁciently translated mRNA and cytosolic mRNA from
three independent biological replicates (as described above). The positive spike-in RNA hybridization
controls for each lane were used to normalize NanoString counts as implemented in the posCtrlNorm
function of the Bioconductor package NanoStringQCPro (108) (with parameter summaryFunction 
“sum”). Targets with fewer than half of the samples above the background level (7 [log2 scale]) were
excluded. The quality of the normalization was assessed by using 30 nonregulated genes selected from
the RNA-Seq data analysis to verify that their expression levels remained stable in the DMSO samples.
Spearman rank correlation coefﬁcients were calculated between fold changes obtained from the
RNA-Seq data and those obtained from the nCounter data. Analysis of translational control was
performed with ANOTA to select targets that were translationally upregulated upon infection with each
T. gondii strain. Genes with an FDR of 0.25 were considered signiﬁcant, and the following parameters
were used: minSlope of 1, maxSlope of 2, and selDeltaPT of log2(1.2). For these targets, empirical
cumulative distribution function (ECDF) curves were used to visualize the distribution of their log2 fold
changes (for both cytosolic and polysome-associated mRNAs) upon treatment with rapamycin or Torin-1.
Distribution differences were evaluated by using Wilcoxon-Mann-Whitney tests.
Functional classiﬁcation of gene lists. Enrichment of translationally regulated genes in speciﬁc
functional networks was determined by using Ingenuity Pathway Analysis (IPA; Qiagen) by comparing
ANOTA-regulated gene sets against the entire sequenced data sets (46). Within the IPA application,
statistical signiﬁcance was calculated by using a right-tailed Fisher exact test, and P values were adjusted
for multiple-hypothesis testing by using the Benjamini-Hochberg method to arrive at a FDR.
RNA sequence motif analyses. For 5= UTR sequence analysis, nonredundant RefSeq 5= UTRs were
retrieved from genome build mm10 using the UCSC table browser (https://genome.ucsc.edu/cgi-bin/
hgTables). The length and GC content of the UTRs were computed by using a custom script. To minimize
the bias associated with analyzing GC contents and sequence motifs of very short sequences, 5= UTRs of
20 nucleotides were omitted from further analyses. Novel RNA sequence motifs were detected in the
5= UTRs by using MEME (Multiple Em for Motif Elicitation) (48). To accurately estimate the probability of
a candidate motif appearing by chance (E value) and to improve the sensitivity of the motif search, a
custom background model was employed. Brieﬂy, the “fasta-get-markov” utility included in the program
was used to compute a background Markov model of order 1 using all RefSeq mouse 5= UTRs. Sequence
logos were generated by using the ggseqLogo package in R. Cap analysis of gene expression (CAGE)-Seq
data were retrieved from FANTOM5 (http://fantom.gsc.riken.jp/5/), and sequences were mapped to the
mm9 build by using the UCSC genome browser.
XTT and [5,6-3H]uracil incorporation viability assays. To test for acute toxicity of the inhibitors
against extracellular tachyzoites, parasite viability was measured by using the tetrazolium reduction-
based XTT assay (109). Brieﬂy, freshly egressed tachyzoites (RH and ME49 strains) were resuspended in
culture medium (without FBS) and transferred to 96-well plates (2  106 tachyzoites per well). Parasites
were treated with 20 nM rapamycin, 200 nM Torin-1, or an equal volume of the vehicle (DMSO) and
incubated for 2 h at 37°C with 5% CO2. As a negative control, heat-killed (HK) parasites incubated at 56°C
for 10 min were included in the assay. Next, the XTT reagents were prepared according to the
manufacturer’s speciﬁcations (Biotium) and added to the parasites. Tachyzoite cultures were incubated
for 20 h. Absorbance was measured by using a Multiskan GO 1510 plate reader (Thermo Fisher) at 470
nm, from which the absorbance at 660 nm was subtracted.
To test for acute toxicity of the inhibitors on intracellular tachyzoites, the incorporation of 5,6-3H-
radiolabeled uracil by the parasite was measured as an assessment of viability (110). Brieﬂy, BMDM were
plated in 24-well plates overnight; serum starved for 2 h; treated with either 20 nM rapamycin, 200 nM Torin-1,
or an equal volume of the vehicle (DMSO); and inoculated with T. gondii tachyzoites (RH and ME49 strains)
at an MOI of 3:1 in fresh medium with 1% heat-inactivated dialyzed FBS. Cultures were incubated overnight,
5 Ci of [5,6-3H]uracil (Perkin-Elmer) was then added to each well, and cultures were incubated for another
2 h at 37°C with 5% CO2. Plates were chilled at 20°C for 2 min, an equal volume of ice-cold 0.6 N
trichloroacetic acid (TCA) was added to each well, and cells were ﬁxed on ice for 1 h. Wells were rinsed with
PBS and then with deionized H2O. Plates were air dried, and the precipitated material was resolubilized in 500
l of 0.1 N NaOH for 1 h. Half of the material was thoroughly mixed with an equal volume of OptiPhase
Supermix scintillation cocktail (Perkin-Elmer), and radioactivity was measured (counts per minute) with a
MicroBeta TriLux scintillation counter (Perkin-Elmer). Uninfected cells were included to measure the back-
ground incorporation of uracil by host cells, and treatment with 10 M pyrimethamine was included as a
positive control for chemical toxicity against T. gondii parasites.
Immunoﬂuorescence microscopy. BMDM were seeded onto glass coverslips in 24-well plates
overnight, serum starved for 2 h, and then inoculated with T. gondii tachyzoites (RH and ME49 strains),
previously stained with 20 M CellTracker green CMFDA dye (Molecular Probes) for 20 min, at an MOI
of 3:1 or left uninfected. After 8 h of infection, cells were rinsed with PBS three times and then ﬁxed with
3.7% paraformaldehyde (PFA) (in PBS) for 15 min at RT. Cell membranes were permeabilized with 0.2%
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Triton X-100 (in PBS) for 5 min at RT. Fc receptors and nonspeciﬁc binding sites were blocked by
incubating samples with 5 g/ml anti-CD16/32 (BioLegend) diluted in PBS supplemented with 10 mg/ml
bovine serum albumin (BSA). Primary antibody against phospho-RPS6 (S240/244) (Cell Signaling Tech-
nologies) was diluted in PBS with 10 mg/ml BSA and incubated with samples for 1 h at RT. A goat
anti-rabbit IgG(HL) secondary antibody conjugated to Alexa Fluor 594 (Invitrogen) was incubated with
the samples for 1 h at RT. Nuclei were stained with 300 nM DAPI (Invitrogen) for 5 min at RT. Coverslips
were mounted onto slides with Fluoromount G (Southern Biotech). Samples were visualized by using a
Leica microscope, and image processing was performed with Fiji (111).
Measurement of parasite replication by qPCR. Parasite replication in vitro was assessed by
extracting genomic DNA (gDNA), followed by measuring the ampliﬁcation of the T. gondii B1 gene by
qPCR, as described previously (101). Brieﬂy, BMDM cultures were plated in 12-well plates overnight;
serum starved for 2 h in the presence of DMSO (vehicle), 20 nM rapamycin, or 200 nM Torin-1; and then
inoculated with T. gondii tachyzoites (RH and ME49 strains) at an MOI of 1:20. Parasites were allowed to
replicate, egress, and reinfect cells for 72 h. Culture supernatants were collected (for extracellular
parasites), while the remaining adherent cells (containing intracellular parasites) were detached by
adding ice-cold PBS with 5 mM EDTA for 15 min at 4°C, followed by vigorous pipetting, and then pooled
into culture supernatants. Tachyzoites and host cells were pelleted by centrifugation (16,000  g for 10
min at 4°C) and then resuspended in 200 l PBS. gDNA was extracted by using a Roche High Pure PCR
template preparation kit, according to the manufacturer’s speciﬁcations. To measure parasite replication,
the 35-fold repetitive T. gondii B1 gene was ampliﬁed by qPCR using the PowerUP SYBR green PCR
master mix (Applied Biosystems) with the MgCl2 concentration adjusted to 3.5 M, 10 ng of template
gDNA, and 0.5 M forward primer (5=-TCCCCTCTGCTGGCGAAAAGT-3=) and reverse primer (5=-AGCGTT
CGTGGTCAACTATCGATTG-3=) (Integrated DNA Technologies) in a 20-l reaction mixture volume. The
reaction was carried out in a QuantStudio 3 real-time PCR system (Applied Biosciences) with the
following program: 10 min of initial denaturation at 95°C, followed by 45 cycles of 15 s of denaturation
at 95°C, 30 s of annealing at 58°C, and 30 s of extension at 72°C. Cycle threshold (CT) values were
normalized by using mouse -actin gene primers (0.2 M forward primer 5=-CACCCACACTGTGCCCATC
TACGA-3= and reverse primer 5=-CAGCGGAACCGCTCATTGCCAATGG-3=), and the MgCl2 concentration
was adjusted to 2.5 M. Analysis was carried out by relative quantiﬁcation using the comparative CT
(2		CT) method (112). The effect of the inhibitors on replication was calculated by normalization to
values obtained from parasite cultures treated with DMSO. Values are presented as means (SD);
experiments on all samples were performed in triplicates.
Statistical analysis. Where applicable, data are presented as means (SD). Statistical signiﬁcance was
determined by using one-way analysis of variance (ANOVA) followed by a Tukey post hoc test; calcula-
tions were performed by using Prism software (GraphPad, La Jolla, CA). Differences were considered
signiﬁcant when P values were 0.05, 0.01, or 0.001.
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